James F. Reddoch, EVP & Chief Scientific Officer at Royalty Pharma plc (RPRX), sold 100,000 shares at $41.56 ($4.2M) on 2022-06-08, disclosed to the SEC on 2022-06-10.
Open-market sale of $4.2M RPRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RPRX | SELL | 2022-05-23 | $3.0M | — | Filing → |
| RPRX | SELL | 2021-07-27 | $712K | — | Filing → |
| RPRX | SELL | 2021-07-14 | $1.5M | — | Filing → |